Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice-Reference-Cited by-同舟云学术

Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice

Published:2001-04 Issue:2 Volume:155 Page:291-295
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Arnal J.F,Castano C,Maupas E,Mugniot A,Darblade B,Gourdy P,Michel J.B,Bayard F

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology;Roques;Pharmacol. Rev.,1993

2. Endothelium-derived relaxing and contracting factors;Furchgott;FASEB J.,1989

3. Supression of atherosclerotic changes in cholesterol-fed rabbits treated with an oral inhibitor of neutral endopeptidase 24.11 (EC 3.4.24.11);Kugiyama;Atheroscler. Thromb. Vasc. Biol.,1996

4. Anti-atherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit;Chobanian;Hypertension,1990

5. Differential effects of renin–angiotensin system blockade on atherogenesis in cholesterol-fed rabbits;Schuh;J. Clin. Invest.,1993

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension;Journal of Pharmacology and Experimental Therapeutics;2021-03-11

2. Sacubitril/valsartan in PARADIGM-HF;The Lancet Diabetes & Endocrinology;2017-07

3. Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory Diarrhea;Journal of Pharmacology and Experimental Therapeutics;2016-02-23

4. C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro;Cell Death & Disease;2015-12

5. Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats;European Journal of Pharmacology;2011-01